• 儀器無憂網(wǎng)首頁
首頁 >  儀器無憂網(wǎng)品牌優(yōu)搜庫 >  Z > 中國制藥裝備行業(yè)協(xié)會

中國 . 中國制藥裝備行業(yè)協(xié)會

logo

中國制藥裝備行業(yè)協(xié)會

CAPE

中國制藥裝備行業(yè)協(xié)會,CAPE ,China Association For Pharmaceutical Equipment  www.phmacn.com
中國制藥裝備行業(yè)協(xié)會成立于1991年,它代表全體會員的共同利益、維護會員的合法權(quán)益,其宗旨是既為政府服務(wù),又為企業(yè)服務(wù)。協(xié)會現(xiàn)有會員單位303家,46位理事,7位副理事長。協(xié)會設(shè)有秘書處、會員管理部、技術(shù)經(jīng)濟部、網(wǎng)絡(luò)信息部、國際部及展覽部。
協(xié)會主要工作:
1、組織起草全國制藥裝備“五年”規(guī)劃(草案);
2、組織制定、修訂制藥裝備產(chǎn)品國家標準、行業(yè)標準,并組織實施;
3、撰寫指導行業(yè)科技進步和行業(yè)發(fā)展的書籍、資料等;
4、制藥裝備行業(yè)的統(tǒng)計工作。
5、制藥裝備行業(yè)自律工作。
6、對制藥裝備企業(yè)的重大基本建設(shè)、技術(shù)改造、產(chǎn)品開發(fā)項目進行前期論證。
7、制藥裝備科技成果鑒定和推廣應(yīng)用工作;組織國內(nèi)、國際制藥機械企業(yè)之間的技術(shù)協(xié)作和技術(shù)交流。
8、組織參與制藥裝備產(chǎn)品的質(zhì)量認證;  
9、舉辦全國和國際制藥機械博覽會;
10、向有關(guān)政府部門反映制藥裝備企業(yè)的愿望與要求。
中國制藥裝備產(chǎn)品有八大類:
原料藥機械及設(shè)備、制劑機械、藥品包裝機械、制藥用水設(shè)備、藥用粉碎機械、飲片機械、藥物檢測設(shè)備、其他制藥設(shè)備
產(chǎn)品服務(wù)于制藥、保健品、食品、化妝品等行業(yè)。現(xiàn)已出口美國、加拿大、墨西哥、阿根廷、巴西、德國、法國、英國、意大利、俄羅斯、日本、韓國、越南、印尼、伊朗、伊拉克、澳大利亞、新西蘭、埃及、香港、澳門等八十多個國家和地區(qū)。
以技術(shù)創(chuàng)新帶動產(chǎn)業(yè)創(chuàng)新,以自主創(chuàng)新帶動產(chǎn)業(yè)升級,更加注重以人為本,全面、協(xié)調(diào)可持續(xù)發(fā)展,為國內(nèi)外的醫(yī)藥工業(yè)發(fā)展作出更大貢獻是我會“十一五”的工作目標。 

China Association For Pharmaceutical Equipment (CAPE in short) was founded in 1991, who represents the benefits of all its members and maintain their legal rights and interest. Its aim is to serve both the China government and pharmaceutical equipment manufacturing enterprises. CAPE currently has about 255 members, 47 commissioners, 8 deputy head and 11 executive commissioners. It is structured by a secretariat office, a member management department, a technical and economic department, a international department, a web section and an exhibition management department.
The main activities of CAPE are as the flowing:
1 Organize and draft Five-Year Plan for pharmaceutical machinery industry;  
2.Organize to formulate and revise the state -level and industry-level standards for pharmaceutical equipment manufacturers;
3 Compose books and materials to instruct and guide the development and advancement for pharmaceutical machinery industry;
4 Conduct the Statistics work for pharmaceutical machinery industry;
5 Preside over the self-discipline issues;
6 Evaluate, in early days, the major fundamental constructions, technology reconstructions and new product development in pharmaceutical machinery industry;
7 Appraise and promote scientific and technological achievements for pharmaceutical machinery, organize technological cooperation and exchanges between domestic and international pharmaceutical machinery companies;
8 Participate in the quality examination and certification issuing works for pharmaceutical products;
9 Host China National Pharmaceutical machinery Exhibition;
10 Render the desires and requirements of pharmaceutical machinery enterprises to relevant China government authorities;
China pharmaceutical industry manufacturer 8 categories of products, such as
Machines and equipment for medicine materials, preparation machines, pharmaceutical packaging machines, water treating machines for pharmaceutical use, pharmaceutical milling machines, pharmaceutical pulverizing machines, medicine detecting instruments as well as other pharmaceutical machineries.
These products meet and satisfy the needs and demands from medicine producers, animal medicine producers, health-care product producers as well as food and cosmetics producers in China. In addition, these products have been also exported to more than eighty countries and areas like United States of America, Canada, Mexico, Argentina, Brazil, Germany, France, England, Italy, Russia, Japan, Korea, Viet Nam, Thailand, Indonesia, Malaysia, the Philippines, Pakistan, Australia, New Zealand, Iran, Iraq, Egypt, Hang Kong and Marco.
Our target in "The Eleventh-five Year" is to drive industry innovation through technical innovation; to bring along the industry updating through self-innovation. Attach more importance to people; coordinate from all aspects to keep continual development of pharmaceutical industry as well as to contribute more to the medicine industry home and abroad.